[go: up one dir, main page]

DE69632854D1 - Wirkstoff zum schutz für organ oder gewebe - Google Patents

Wirkstoff zum schutz für organ oder gewebe

Info

Publication number
DE69632854D1
DE69632854D1 DE69632854T DE69632854T DE69632854D1 DE 69632854 D1 DE69632854 D1 DE 69632854D1 DE 69632854 T DE69632854 T DE 69632854T DE 69632854 T DE69632854 T DE 69632854T DE 69632854 D1 DE69632854 D1 DE 69632854D1
Authority
DE
Germany
Prior art keywords
tissue
group
active substance
protect organic
protect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69632854T
Other languages
English (en)
Other versions
DE69632854T2 (de
Inventor
Mikio Ota
Hideki Teijin Limited Horiuchi
Shigehisa Kitahara
Shiro Kondo
Yasuhiro Takano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13778322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69632854(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE69632854D1 publication Critical patent/DE69632854D1/de
Publication of DE69632854T2 publication Critical patent/DE69632854T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69632854T 1995-04-07 1996-04-04 Schutzmittel für Organe und Gewebe Expired - Lifetime DE69632854T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8257695 1995-04-07
JP8257695 1995-04-07
PCT/JP1996/000924 WO1996031211A1 (fr) 1995-04-07 1996-04-04 Agent protecteur pour organe ou tissu

Publications (2)

Publication Number Publication Date
DE69632854D1 true DE69632854D1 (de) 2004-08-12
DE69632854T2 DE69632854T2 (de) 2005-07-14

Family

ID=13778322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632854T Expired - Lifetime DE69632854T2 (de) 1995-04-07 1996-04-04 Schutzmittel für Organe und Gewebe

Country Status (11)

Country Link
US (1) US5843969A (de)
EP (1) EP0779074B1 (de)
JP (1) JP3194964B2 (de)
KR (1) KR100308332B1 (de)
AT (1) ATE270550T1 (de)
AU (1) AU703609B2 (de)
CA (1) CA2190993C (de)
DE (1) DE69632854T2 (de)
ES (1) ES2224160T3 (de)
TW (1) TW425284B (de)
WO (1) WO1996031211A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1488790B1 (de) * 2002-03-28 2014-07-16 Teijin Pharma Limited Feste zubereitung enthalten eine einzelne kristall a-form eines thiazolkohlensäure-derivates
ATE440820T1 (de) * 2004-08-27 2009-09-15 Astellas Pharma Inc 2-phenylpyridinderivat
US7612108B2 (en) * 2004-08-27 2009-11-03 Astellas Pharma Inc. 2-phenylthiophene derivative
EP1883405A4 (de) 2005-05-09 2010-01-27 Takeda Pharmaceuticals North A Verfahren zur behandlung von nephrolithiase
ES2355068T3 (es) 2005-10-07 2011-03-22 Astellas Pharma Inc. Derivado del ácido triarilcarboxílico.
CA2643272A1 (en) * 2006-02-24 2007-08-30 Astellas Pharma Inc. Gent for treating or preventing digestive ulcer
EP2050467B1 (de) * 2006-07-19 2014-09-10 Nippon Medical School Foundation Therapeutisches mittel für amyotrophe lateralsklerose
KR20160031040A (ko) * 2006-11-13 2016-03-21 다케다 파마슈티칼스 유에스에이, 인코포레이티드 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법
PH12012502485A1 (en) 2010-06-16 2022-10-05 Takeda Pharmaceuticals Usa Inc Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
KR101797936B1 (ko) 2010-09-10 2017-11-15 다케다 파마슈티칼스 유에스에이, 인코포레이티드 테오필린과 페북소스타트의 병용 치료 방법
TW201328692A (zh) * 2011-10-11 2013-07-16 Univ Osaka 脫髓鞘疾病之治療劑及預防劑
EP2692342A1 (de) * 2012-07-30 2014-02-05 Interquim, S.A. Verfahren zur Herstellung pharmazeutischer Zusammensetzungen mit Febuxostat in Tablettenform
CN103848798B (zh) 2012-11-30 2016-01-06 镇江新元素医药科技有限公司 2-芳基硒唑化合物及其药物组合物
TWI606048B (zh) 2013-01-31 2017-11-21 帝人製藥股份有限公司 唑苯衍生物
RS58315B1 (sr) * 2014-07-30 2019-03-29 Teijin Pharma Ltd Derivat azol benzena i njegov kristal
RS57797B1 (sr) 2014-07-30 2018-12-31 Teijin Pharma Ltd Kristal derivata azol benzena kao inhibotor ksantin oksidaze
KR102259713B1 (ko) 2014-07-30 2021-06-01 데이진 화-마 가부시키가이샤 크산틴옥시다아제 저해약

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2877508B2 (ja) * 1989-02-08 1999-03-31 アボツト・ラボラトリーズ ５―リポキシゲナーゼ阻止剤としての４―ヒドロキシチアゾール
JP2665564B2 (ja) * 1989-08-25 1997-10-22 株式会社大塚製薬工場 細胞防護剤
AU649245B2 (en) * 1990-04-02 1994-05-19 Amgen, Inc. Methods for treating interleukin-1 mediated diseases
JPH04117371A (ja) * 1990-09-05 1992-04-17 Otsuka Pharmaceut Factory Inc チアゾール誘導体
ATE142494T1 (de) * 1990-11-30 1996-09-15 Teijin Ltd 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
US6090775A (en) * 1991-10-31 2000-07-18 The Victoria University Of Manchester Treatment of neurological conditions by an interleukin-1 inhibiting compound
JPH05320072A (ja) * 1992-05-20 1993-12-03 Taiho Yakuhin Kogyo Kk 虚血性脳疾患治療薬

Also Published As

Publication number Publication date
DE69632854T2 (de) 2005-07-14
CA2190993A1 (en) 1996-10-10
JP3194964B2 (ja) 2001-08-06
EP0779074A4 (de) 1999-06-30
ATE270550T1 (de) 2004-07-15
KR100308332B1 (ko) 2002-09-17
EP0779074A1 (de) 1997-06-18
EP0779074B1 (de) 2004-07-07
TW425284B (en) 2001-03-11
AU5162396A (en) 1996-10-23
AU703609B2 (en) 1999-03-25
US5843969A (en) 1998-12-01
ES2224160T3 (es) 2005-03-01
WO1996031211A1 (fr) 1996-10-10
CA2190993C (en) 2004-06-01

Similar Documents

Publication Publication Date Title
DE69632854D1 (de) Wirkstoff zum schutz für organ oder gewebe
NO970892L (no) Isoksazolderivater
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
DE60017115D1 (de) Amid-derivate und deren medizinische verwendung
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
BR1100636A (pt) Agente terapêutico para o mal de parkinson, e, derivado da xantina
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
PT1209166E (pt) Novos derivados de a-500359
NO921282D0 (no) Benzotiazolderivater og deres anvendelse
NO931752L (no) Oktahydronaftalenoksimderivater til inhibering av kolesterolbiosyntese, samt fremgangsm}te til fremstilling og anvendelse derav
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
DE69532963D1 (de) Verwendung von 4-acylaminopyridin derivaten zur Herstellung eines Medikaments für die Behandlung von zerebrovaskulären Erkrankungen
TH31635A (th) อนุพันธ์คาร์โบไฮเดรต
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition